News

Biosenta granted to Lightweight Concrete Solutions a license to use Biosenta’s Tri-Filler® technology and get fee of C$200,000 and royalties

Biosenta has closed its private placement for gross proceeds of $600,000.

Biosenta announces a non-brokered private placement financing of up to $600,000.

Biosenta announces technological and operational advancements with successful construction and operation of a bench scale production plant.

Amarvir Gill, President, CEO and Director of Biosenta acquired 1,250,000 common shares and 625,000 warrants.